The impact of synbiotic on serum paraoxonase 1, (sCD163/sTWEAK) and lipid profile in patients with chronic heart failure: a randomized, triple-blind, controlled trial

Author:

Matin Shakiba Shoaei1,Shidfar Farzad1,Naderi Nasim1,Amin Ahmad1,Hosseini-Baharanchi Fatemeh Sadat1,dehnad Afsaneh1

Affiliation:

1. Iran University of Medical Sciences

Abstract

Abstract Background: Cardiovascular disease is one of the leading causes of death worldwide. Evidence suggests that alterations in the gut microbiome could play a role in cardiovascular diseases including heart failure. Objective: The purpose of this study was to evaluate the effect of synbiotics on serum paraoxonase 1(PON1), (sCD163/sTWEAK) and lipid profile, which are involved in heart failure in patients with chronic heart failure. Method: In this triple-blind randomized clinical trial, 90 eligible patients were included in the study. They were randomly assigned to receive one capsule (500 mg) of synbiotics or a placebo per day for 10 weeks. serum paraoxonase 1(PON1), (sCD163/sTWEAK), and lipid profile were measured at the beginning and end of the study. The data were analyzed by SPSS 24, and the p-value <0.05 was considered statistically significant. Result: Among 90 patients who met the inclusion criteria, 80 patients completed the study. At the end of the intervention, and after adjusting for the effect of confounders, the levels of total cholesterol (TC), LDL-c, Triglyceride and TC/HDL-C showed a significant decrease. However, we found no significant differences between the groups when considering other study indices. Conclusion: A favorable effect of synbiotics on the lipid profile of patients with heart failure was observed, but no statistically significant effect was found on paraoxinase1, sCD163, and sTWEAK factors Registration number: IRCT20091114002709N55

Publisher

Research Square Platform LLC

Reference47 articles.

1. Decompensated heart failure;Mangini S;Einstein (Sao Paulo),2013

2. Heart failure with reduced ejection fraction;Bloom MW;Nat reviews Disease primers,2017

3. Epidemiology of heart failure;Roger VL;Circul Res,2013

4. Shrivastava A, Haase T, Zeller T, Schulte C. Biomarkers for heart failure prognosis: proteins, genetic scores, and non-coding RNAs.Frontiers in Cardiovascular Medicine. 2020:252.

5. Diminished antioxidant activity of high-density lipoprotein–associated proteins in systolic heart failure;Tang WW;Circulation: Heart Failure,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3